prikaz prve stranice dokumenta Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling
Rad nije dostupan
Znanstveni rad - Izvorni znanstveni rad
Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling
Biochemical and biophysical research communications, 487 (2017), 4; 782-788. https://doi.org/10.1016/j.bbrc.2017.04.100


Citirajte ovaj rad

Grbčić, P., Tomljanović, I., Klobučar, M., Kraljević Pavelić, S., Lučin, K. i Sedić, M. (2017). Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling. Biochemical and biophysical research communications, 487. (4), 782-788. doi: 10.1016/j.bbrc.2017.04.100

Grbčić, Petra, et al. "Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling." Biochemical and biophysical research communications, vol. 487, br. 4, 2017, str. 782-788. https://doi.org/10.1016/j.bbrc.2017.04.100

Grbčić, Petra, Ivana Tomljanović, Marko Klobučar, Sandra Kraljević Pavelić, Ksenija Lučin i Mirela Sedić. "Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling." Biochemical and biophysical research communications 487, br. 4 (2017): 782-788. https://doi.org/10.1016/j.bbrc.2017.04.100

Grbčić, P., et al. (2017) 'Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling', Biochemical and biophysical research communications, 487(4), str. 782-788. doi: 10.1016/j.bbrc.2017.04.100

Grbčić P, Tomljanović I, Klobučar M, Kraljević Pavelić S, Lučin K, Sedić M. Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling. Biochemical and biophysical research communications [Internet]. 2017. [pristupljeno 29.05.2024.];487(4):782-788. doi: 10.1016/j.bbrc.2017.04.100

P. Grbčić, I. Tomljanović, M. Klobučar, S. Kraljević Pavelić, K. Lučin i M. Sedić, "Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling", Biochemical and biophysical research communications, vol. 487, br. 4, str. 782-788, 2017. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:898401. [Citirano: 29.05.2024.]